The Centers for Medicare & Medicaid Services has selected 61 applicants for the Value in Opioid Use Disorder Treatment Demonstration, a four-year Medicare payment model beginning this month for selected health care providers who agree to participate.

Participants will test whether a new care management fee and performance-based incentive payment for OUD treatment services reduces hospitalizations and improves health outcomes for Medicare fee-for-service patients with OUDs, including those dually eligible for Medicaid. The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 authorizes $10 million annually in fiscal years 2021-2024 to pay for the treatment services. 

Related News Articles

Headline
The AHA July 16 urged the Center for Medicare and Medicaid Innovation not to implement its newly proposed Increasing Organ Transplant Access Model as currently…
Headline
The AHA July 15 commented to Sens. Sheldon Whitehouse, D-R.I., and Bill Cassidy, R-La., responding to a request for information based on the Pay PCPs Act,…
Headline
The Centers for Medicare & Medicaid Services July 2 announced that Maryland, Vermont and Connecticut will be the first participants in the States Advancing…
Headline
An infographic released by the University of Minnesota Rural Health Research Center highlights the decline of maternity care access in rural counties across…
Headline
The Centers for Medicare & Medicaid Services July 10 released its calendar year 2025 proposed rule for the physician fee schedule. The rule proposes to cut…
Headline
Improving access to rural health care is a top priority for AHA, and its 2024 Rural Advocacy Agenda lays the groundwork to improve the system as a whole. In…